Novartis Cosentyx® positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis

NEXT STORY
Nurse Call Systems Market to Reach USD 2.79 Billion by 2026; Rising Incidence of Chronic Diseases to Propel Market, says Fortune Business Insights
PREV STORY
Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Reports Preliminary Fourth Quarter and Full Year 2018 Revenue

Announces Long-Term Strategic TargetsMEDFORD, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. ...

author_avatar
NASDAQ Market News

Selecta Biosciences Announces Upcoming Clinical Presentations

WATERTOWN, Mass., June 06, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News

Merit Medical Enters Strategic Alliance and Worldwide Distribution with NinePoint Medical

SOUTH JORDAN, Utah, May 02, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), ...

author_avatar
NASDAQ Market News